Skip to content

SCHEDULE 13G/AAccepted May 14, 4:19 PM ET

Day One Biopharmaceuticals, Inc. SCHEDULE 13G/A

Atlas Venture Fund XI, L.P.

Accepted (ET)

4:19 PM

May 14, 2026

Filed

May 14, 2026

Documents

2

Size

56.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.